FLT3 mutations are one of the most common findings in acute myeloid leukemia (AML).
FLT3 inhibitors have been in active clinical development. Midostaurin as the first-in-class …

Skin cancer encompasses a range of cutaneous malignancies, with non-melanoma skin
cancers (NMSCs) being the most common neoplasm worldwide. Skin exposure is the …

Merkel cell carcinoma is a rare neuroendocrine carcinoma that typically appears in sun‐
exposed areas of the elderly. It has a poor prognosis and with its incidence projected to …

Simple Summary Merkel cell carcinoma (MCC) is a highly aggressive skin cancer and the
second cause of skin cancer death after melanoma. MCC is an immunogenic tumor. In …

Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer
whose incidence has almost doubled in recent decades. Risk factors for MCC include age> …

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma with a high rate of
metastasis and 5-year overall survival (OS) ranging from 50.6% for patients with local …

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of
local recurrence and distant metastasis. Optimal care of this potentially life-threatening …

Background Merkel cell carcinoma (MCC) is an aggressive, high‐grade, cutaneous
neuroendocrine tumour (NET). Agents blocking programmed death 1/programmed death …

Although rare, Merkel cell carcinoma (MCC) is a highly aggressive and increasingly
prevalent neuroendocrine cancer of the skin. While current interventions, including surgical …

Merkel cell carcinoma (MCC) is a rare, rapidly progressing, and difficult-to-treat
neuroendocrine tumor of the skin that is associated with high mortality. In the last few …